Published in Genome Med on May 28, 2012
The Epigenome View: An Effort towards Non-Invasive Prenatal Diagnosis. Genes (Basel) (2014) 0.79
Non-Invasive Screening Tools for Down's Syndrome: A Review. Diagnostics (Basel) (2013) 0.75
Detection of fetal epigenetic biomarkers through genome-wide DNA methylation study for non-invasive prenatal diagnosis. Mol Med Rep (2017) 0.75
The epigenomics of cancer. Cell (2007) 30.91
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A (1996) 29.54
DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08
The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol (2003) 16.17
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet (2005) 15.37
Digital PCR. Proc Natl Acad Sci U S A (1999) 10.54
Presence of fetal DNA in maternal plasma and serum. Lancet (1997) 9.01
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A (2008) 8.38
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet (1998) 6.88
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A (2008) 5.94
Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res (2001) 5.89
Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci U S A (1999) 5.63
DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med (2011) 4.98
An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res (2008) 4.84
Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol (2012) 4.78
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ (2011) 4.50
Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med (1998) 4.29
Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol (2011) 4.18
A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet (2007) 3.86
Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem (2002) 3.72
Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med (2007) 3.34
[Not Available]. C R Seances Soc Biol Fil (1948) 3.32
Epigenomics: beyond CpG islands. Nat Rev Genet (2004) 3.21
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med (2012) 3.18
Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res (1999) 3.15
Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A (2007) 3.13
Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol (2006) 2.90
Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn (2012) 2.79
Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem (2004) 2.79
Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem (2008) 2.78
Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem (2002) 2.74
Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol (2007) 2.55
Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA (2004) 2.53
Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Clin Chem (2006) 2.41
Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen (1996) 2.38
Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One (2011) 2.29
Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med (2011) 2.19
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res (1999) 2.19
Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem (2011) 2.17
Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci U S A (1990) 2.15
Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem (2008) 2.14
Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One (2010) 2.11
The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update (2008) 2.04
Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet (2000) 2.01
mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A (2003) 1.89
Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med (2011) 1.85
PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet (1997) 1.84
Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A (2005) 1.81
Detection of aneuploidy with digital polymerase chain reaction. Anal Chem (2007) 1.80
Clinical practice. Prenatal screening for aneuploidy. N Engl J Med (2009) 1.80
Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem (2009) 1.80
Life-span of the fetal red blood cell. J Pediatr (1967) 1.79
Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem (2004) 1.79
Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol (2005) 1.75
Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn (2002) 1.74
Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol (2007) 1.63
Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res (1999) 1.58
Single molecule sequencing of free DNA from maternal plasma for noninvasive trisomy 21 detection. Clin Chem (2012) 1.52
Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem (2001) 1.50
Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol (2009) 1.46
Detection of trisomy 18 and Y-derived sequences in fetal nucleated cells obtained by transcervical flushing. Lancet (1993) 1.46
Presence of fetal RNA in maternal plasma. Clin Chem (2000) 1.45
Noninvasive prenatal diagnosis in 2020. Prenat Diagn (2010) 1.42
Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online (2007) 1.34
Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem (2002) 1.33
Allele drop-out can occur in alleles differing by a single nucleotide and is not alleviated by preamplification or minor template increments. Genet Test (1998) 1.31
Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. Reproduction (2003) 1.27
Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess (2003) 1.26
Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry. Am J Obstet Gynecol (1991) 1.23
Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens (1997) 1.19
Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem (2009) 1.18
Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet (2001) 1.13
Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem (2004) 1.13
MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci U S A (2004) 1.12
Fetal cells in maternal blood: recovery by charge flow separation. Hum Genet (1996) 1.11
Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clin Chem (2005) 1.05
Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem (2003) 1.04
Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet (2001) 1.04
The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis. Prenat Diagn (1997) 1.03
Detection of circulating fetal nucleic acids: a review of methods and applications. J Clin Pathol (2009) 1.01
Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet (2004) 1.00
Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study. Prenat Diagn (2009) 0.99
Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis. Hum Reprod Update (2002) 0.97
[Post-partum survival of fetal lymphocytes in the maternal blood]. Schweiz Med Wochenschr (1977) 0.97
Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clin Chem (2005) 0.97
Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn (2002) 0.96
Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem (2001) 0.96
Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker. PLoS One (2010) 0.94
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis. Clin Chem (2008) 0.89
Invasive prenatal diagnostic techniques. Semin Perinatol (2005) 0.88
What potent blood: non-invasive prenatal genetic diagnosis and the transformation of modern prenatal care. Am J Law Med (2007) 0.88
A morphologic study of trophoblast isolated from peripheral blood of pregnant women. Am J Obstet Gynecol (1994) 0.88
Prenatal diagnosis of Down's syndrome. Lancet (1968) 0.87
Magnetic cell sorting and the transferrin receptor as potential means of prenatal diagnosis from maternal blood. Am J Obstet Gynecol (1992) 0.87
Detection of trisomy 21 by quantitative mass spectrometric analysis of single-nucleotide polymorphisms. Clin Chem (2005) 0.86
Recent progress in non-invasive prenatal diagnosis. Semin Fetal Neonatal Med (2008) 0.86
Arrayed primer extension for the noninvasive prenatal diagnosis of beta-thalassemia based on detection of single nucleotide polymorphisms. Ann N Y Acad Sci (2008) 0.84
A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma. Methods Mol Biol (2008) 0.83
HLA-G positive trophoblastic cells in transcervical samples and their isolation and analysis by laser microdissection and QF-PCR. Prenat Diagn (2003) 0.83
Rapid prenatal diagnosis of aneuploidy from uncultured amniotic fluid cells using five-colour fluorescence in situ hybridization. Prenat Diagn (1994) 0.82
MeDIP real-time qPCR of maternal peripheral blood reliably identifies trisomy 21. Prenat Diagn (2012) 2.23
Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med (2011) 2.19
Guidelines for molecular karyotyping in constitutional genetic diagnosis. Eur J Hum Genet (2007) 1.56
Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol (2009) 1.46
21 Mb deletion in chromosome band 13q22.2q32.1 associated with mild/moderate psychomotor retardation, growth hormone insufficiency, short neck, micrognathia, hypotonia, dysplastic ears and other dysmorphic features. Eur J Med Genet (2011) 1.38
Cryptic genomic imbalances in patients with de novo or familial apparently balanced translocations and abnormal phenotype. Mol Cytogenet (2008) 1.23
The cypriot and Iranian National Mutation Frequency Databases. Hum Mutat (2006) 1.08
Clinical application of whole-genome array CGH during prenatal diagnosis: Study of 25 selected pregnancies with abnormal ultrasound findings or apparently balanced structural aberrations. Mol Cytogenet (2010) 0.97
FoSTeS, MMBIR and NAHR at the human proximal Xp region and the mechanisms of human Xq isochromosome formation. Hum Mol Genet (2011) 0.92
Cytogenetic Guidelines and Quality Assurance: a common European framework for quality assessment for constitutional and acquired cytogenetic investigations. Eur J Hum Genet (2007) 0.92
Clinical and molecular characterization of a second case of 7p22.1 microduplication. Am J Med Genet A (2012) 0.91
A single gene deletion on 4q28.3: PCDH18--a new candidate gene for intellectual disability? Eur J Med Genet (2012) 0.90
Distal del(4) (q33) syndrome: detailed clinical presentation and molecular description with array-CGH. Eur J Med Genet (2007) 0.88
263.4 kb deletion within the TCF4 gene consistent with Pitt-Hopkins syndrome, inherited from a mosaic parent with normal phenotype. Eur J Med Genet (2013) 0.87
Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidies. J Mol Diagn (2010) 0.86
Implementation of high resolution whole genome array CGH in the prenatal clinical setting: advantages, challenges, and review of the literature. Biomed Res Int (2013) 0.85
Array-CGH analysis and clinical description of 2q37.3 de novo subtelomeric deletion. Eur J Med Genet (2006) 0.85
Molecular defects of the CYP21A2 gene in Greek-Cypriot patients with congenital adrenal hyperplasia. Horm Res Paediatr (2010) 0.84
Mosaic trisomy r(14) associated with epilepsy and mental retardation. J Child Neurol (2007) 0.82
A gene for nonsyndromic X-linked mental retardation (MRX77) maps to Xq12-Xq21.33. Am J Med Genet A (2003) 0.80
Considering specific clinical features as evidence of pathogenic copy number variants. J Appl Genet (2014) 0.80
Mental retardation and autism associated with recurrent 16p11.2 microdeletion: incomplete penetrance and variable expressivity. J Appl Genet (2011) 0.79
De novo 5q35.5 duplication with clinical presentation of Sotos syndrome. Am J Med Genet A (2011) 0.78
Multiplex Amplifiable Probe Hybridization (MAPH) methodology as an alternative to comparative genomic hybridization (CGH). Methods Mol Biol (2010) 0.78
A new chromosome x exon-specific microarray platform for screening of patients with X-linked disorders. J Mol Diagn (2009) 0.77
Screening of 20 patients with X-linked mental retardation using chromosome X-specific array-MAPH. Eur J Med Genet (2007) 0.77
Variability of ffDNA in maternal plasma does not prevent correct classification of trisomy 21 using MeDIP-qPCR methodology. Prenat Diagn (2013) 0.77
9 Mb familial duplication in chromosome band Xp22.2-22.13 associated with mental retardation, hypotonia and developmental delay, scoliosis, cardiovascular problems and mild dysmorphic facial features. Eur J Med Genet (2011) 0.77
Maternal plasma sequencing: a powerful tool towards fetal whole genome recovery. BMC Med (2013) 0.75
Screening of 50 cypriot patients with autism spectrum disorders or autistic features using 400K custom array-CGH. Biomed Res Int (2013) 0.75
Author's response regarding "MeDIP-qPCR approach for non-invasive prenatal diagnosis of Down syndrome: accuracy and reproducibility". Prenat Diagn (2013) 0.75
Response to the Alvarez Nava and Puerta "Y-chromosome microdeletions in 45,X/46,XY patients". Am J Med Genet A (2006) 0.75
5alpha-reductase 2 gene mutations in three unrelated patients of Greek Cypriot origin: identification of an ancestral founder effect. J Pediatr Endocrinol Metab (2005) 0.75
Evaluation of whole-genome amplification using multiple-displacement amplification of a limited number of cells. Clin Chem Lab Med (2006) 0.75
Array-MAPH: a methodology for the detection of locus copy-number changes in complex genomes. Nat Protoc (2008) 0.75
Application of two different microarray-based copy-number detection methodologies--array-comparative genomic hybridization and array-multiplex amplifiable probe hybridization--with identical amplifiable target sequences. Clin Chem Lab Med (2008) 0.75
Complete androgen insensitivity syndrome caused by the R855H mutation in the androgen receptor gene. J Pediatr Endocrinol Metab (2005) 0.75
Unbalanced translocations involving chromosome region 10q25.3q26.3 in patients with intellectual disability and complex phenotypes. Cytogenet Genome Res (2015) 0.75
Duplication of exons 3-10 of the HSD17B3 gene: a novel type of genetic defect underlying 17β-HSD-3 deficiency. Gene (2012) 0.75